World's Best Scientists 2026 revealed!
Paola Cipriani

Paola Cipriani

D-Index & Metrics

Immunology

D-Index
57
Citations
11117
World Ranking
3633
National Ranking
147

Overview

Paola Cipriani is affiliated with the University of L'Aquila in Italy and has contributed extensively to the field of Medicine, with a particular focus on Rheumatology, Hematology, Immunology, Surgery, and Pathology and Forensic Medicine. Their research output includes a significant number of publications in these areas, reflecting a broad engagement with clinical and experimental medical sciences.

The primary fields of study for Cipriani encompass:

  • Medicine

More specifically, the subfields they have focused on include:

  • Rheumatology
  • Hematology
  • Immunology
  • Surgery
  • Pathology and Forensic Medicine

Cipriani's main research topics involve several autoimmune and inflammatory conditions and their treatment strategies, including:

  • Autoimmune and Inflammatory Disorders Research
  • Rheumatoid Arthritis Research and Therapies
  • Spondyloarthritis Studies and Treatments
  • Kawasaki Disease and Coronary Complications
  • Systemic Sclerosis and Related Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Systemic Lupus Erythematosus Research

Among frequently publishing coauthors are:

  • Roberto Giacomelli
  • Piero Ruscitti
  • Onorina Berardicurti
  • Ilenia Di Cola
  • Luca Navarini

Paola Cipriani has contributed to several publication venues, with multiple works appearing in:

  • Annals of the Rheumatic Diseases
  • Clinical and Experimental Rheumatology
  • Autoimmunity Reviews
  • Frontiers in Medicine
  • Scientific Reports

A selection of recent papers coauthored by Cipriani includes:

  • "Beyond the joints, the extra-articular manifestations in rheumatoid arthritis," 2020, Autoimmunity Reviews
  • "Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm," 2020, Frontiers in Immunology
  • "The economic burden of fibromyalgia: A systematic literature review," 2022, Seminars in Arthritis and Rheumatism
  • "The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus," 2020, Autoimmunity Reviews
  • "Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations," 2020, Scientific Reports

Best Publications

  • Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.

    Alessandro Conforti;Ilenia Di Cola;Viktoriya Pavlych;Piero Ruscitti

  • Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?

    Alessandra Marrelli;Paola Cipriani;Vasiliki Liakouli;Francesco Carubbi

  • The role of IL-1β in the bone loss during rheumatic diseases.

    Piero Ruscitti;Paola Cipriani;Francesco Carubbi;Vasiliki Liakouli

  • Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry

    Fabiola Atzeni;Piercarlo Sarzi-Puttini;Costantino Botsios;Antonio Carletto

  • Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

    Francesco Carubbi;Paola Cipriani;Alessandra Marrelli;Paola Di Benedetto

  • Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.

    P. Cipriani;S. Guiducci;I. Miniati;M. Cinelli

  • Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis

    Roberto Giacomelli;Gabriele Valentini;Felice Salsano;Paola Cipriani

  • Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

    Piero Ruscitti;Paola Cipriani;Francesco Masedu;Daniela Iacono

  • International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Chiara Baldini

  • Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

    P. Ruscitti;P. Cipriani;P. Di Benedetto;V. Liakouli

  • Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia.

    F Berlutti;C Morea;A Battistoni;S Sarli

  • Methotrexate: an old new drug in autoimmune disease

    Paola Cipriani;Piero Ruscitti;Francesco Carubbi;Vasiliki Liakouli

  • Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Elena Bartoloni-Bocci

  • The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

    Mirko Manetti;Lidia Ibba-Manneschi;Vasiliki Liakouli;Serena Guiducci

  • The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist

    Paola Cipriani;Paola Di Benedetto;Piero Ruscitti;Daria Capece

  • Angiogenic cytokines and growth factors in systemic sclerosis

    Vasiliki Liakouli;Paola Cipriani;Alessandra Marrelli;Saverio Alvaro

  • Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors.

    Florenzo Iannone;Elisa Gremese;Fabiola Atzeni;Domenico Biasi

  • Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial

    Piero Ruscitti;Francesco Masedu;Saverio Alvaro;Paolo Airò

  • Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion

    R Perricone;C De Carolis;B Kröegler;E Greco

  • Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.

    Paola Cipriani;Piero Ruscitti;Francesco Carubbi;Ilenia Pantano

  • Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.

    Serena Colafrancesco;Roberta Priori;Guido Valesini;Lorenza Argolini

Frequent Co-Authors

Roberto Giacomelli
Roberto Giacomelli Campus Bio Medico University Hospital
Roberto Gerli
Roberto Gerli University of Perugia
Alessia Alunno
Alessia Alunno University of L'Aquila
Giovanni Cioni
Giovanni Cioni University of Pisa
Roberto Perricone
Roberto Perricone University of Rome Tor Vergata
Francesco Caso
Francesco Caso University of Naples Federico II
Fabiola Atzeni
Fabiola Atzeni University of Messina
Marco Matucci-Cerinic
Marco Matucci-Cerinic University of Florence
Riccardo Alessandro
Riccardo Alessandro University of Palermo
Carlo Perricone
Carlo Perricone University of Perugia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often opens doors to various specialized healthcare roles, including advanced nursing positions. For those interested in combining clinical expertise with research, exploring top PMHNP programs can provide valuable insights into mental health, a crucial aspect of immunological disorders. Programs highlighted in top pmhnp programs are known for their excellent clinical placement rates, ensuring hands-on experience alongside theoretical knowledge.

Cost is a significant factor for many students pursuing further education. Identifying more affordable options without compromising quality is essential. The list of cheapest online pmhnp certificate programs offers a great starting point for those balancing budget and career advancement goals.

Career growth in fields tied to Immunology or nursing specialties often comes with varying salary potentials. Understanding the dnp salary by state can help professionals make informed decisions about job locations and negotiate better compensation packages.

For nurses seeking to expand their expertise, transitioning from a Family Nurse Practitioner (FNP) role to an acute care setting is a common pathway. Guidance on how to make this shift effectively can be found in resources about fnp to acute care np, which provides practical steps and certification requirements.

Best Scientists Citing Paola Cipriani

Trending Scientists